Chemoimmunotherapy Intratumoral ahaziri ahazi nke dị ọnụ ala-Opekempe

Chemoimmunotherapy Intratumoral ahaziri ahazi nke dị ọnụ ala-Opekempe, ma ọ bụ CIIC, na-anọchi anya ụzọ na-ekwe nkwa ma na-esiwanye ike inweta ọgwụgwọ ọrịa kansa. Usoro a na-ejikọta izi ezi nke ịwa ahụ dị ntakịrị na nnyefe ezubere iche nke chemotherapy na immunotherapy ozugbo na etuto ahụ, na-achọ njikwa etuto ahụ dị irè yana mmetụta dị nta karịa ọgwụgwọ usoro ọdịnala. Ụzọ ahaziri onwe ya dị oke mkpa, na-eme ka usoro ọgwụgwọ ahụ dịrị onye ọrịa n'otu n'otu na njirimara etuto ha kpọmkwem. Ịghọta Chemoimmunotherapy Intratumoral chemoimmunotherapy gụnyere ịgbanye ọgwụ chemotherapeutic na/ma ọ bụ ọgwụ immunotherapeutic ozugbo n'ime ụbụrụ. Nnyefe mpaghara a na-ebuli itinye uche ọgwụ n'ime etuto ahụ ka ọ na-ebelata mkpughe nke sistemu, nwere ike ibelata mmetụta ọjọọ a na-ejikọkarị na chemotherapy system.Uru nke Chemoimmunotherapy Intratumoral. Mbelata nsí sistemu: Site n'ilekwasị anya ozugbo na etuto ahụ, a na-ebelata ikpughe usoro ọgwụgwọ ọgwụ chemotherapy, na-ebute obere mmetụta dị ka ọgbụgbọ, ntutu isi, na ike ọgwụgwụ. Nzaghachi nke mgbochi ọrịa: Intratumoral injection nwere ike kpalie nzaghachi mgbochi nke mpaghara, nke nwere ike ibute nsonaazụ abscopal (nkwụghachi tumor na saịtị dị anya). Ọgwụgwọ ahaziri onwe ya: Enwere ike ịhazi usoro ọgwụgwọ ahụ dabere na njirimara akpụ nke onye ọrịa, na-eme ka ọ dị mma. Obere wakpo: Usoro a na-agụnye obere mbepụ ma ọ bụ ntinye agịga, na-akpata obere mgbu, oge mgbake dị mkpirikpi, na mbelata ihe ize ndụ nke nsogbu ma e jiri ya tụnyere ịwa ahụ omenala.Ultra-Opekempe mwepu mbepụ usoro, nke a makwaara dị ka percutaneous usoro, na-eji ihe oyiyi nduzi (dịka, ultrasound, CT scan) iji nye kpọmkwem akpụ akpụ. Ụzọ a na-ebelatakwa mmerụ ahụ n'anụ ahụ gbara ya gburugburu ma mee ka mgbake dị ngwa ngwa. Uru nke Ultra-Opekempe mbepụ. Mbelata na mgbu na ọnya: Obere mbepụ na-ebute obere mgbu yana ọnya dị nta. Ọsọ mgbake: Ndị ọrịa na-enwekarị mgbake ngwa ngwa wee laghachi n'ọrụ ha. Usoro ụlọ ọgwụ: N'ọtụtụ ọnọdụ, enwere ike ịme ultra-minimum intratumoral chemoimmunotherapy dị ka usoro nlekọta ahụike, na-ewepụ mkpa maka ịnọ n'ụlọ ọgwụ. Ezubere iche nke ọma: Ntuziaka onyonyo na-eme ka nnyefe ziri ezi nke ndị na-ahụ maka ọgwụgwọ na etuto ahụ. Ụzọ nkeonwe maka Chemoimmunotherapy ọgwụ nkeonwe bụ n'ihu ọgwụgwọ ọrịa kansa. Ya na Chemoimmunotherapy Intratumoral ahaziri ahazi nke dị ọnụ ala-Opekempe, A na-ahazi atụmatụ ọgwụgwọ maka onye ọrịa ọ bụla dabere na ihe ndị dị ka: Ụdị Tumor na Ọkwa: Ụdị etuto dị iche iche na-anabata chemotherapy na immunotherapy dị iche iche. Nhazi na-enyere aka ịchọpụta oke ọrịa ahụ. Nkọwapụta mkpụrụ ndụ ihe nketa na mkpụrụ ndụ: Nyochaa usoro mkpụrụ ndụ ihe nketa nke etuto ahụ nwere ike ịchọpụta ebumnuche a kapịrị ọnụ maka ọgwụgwọ. Akụkọ gbasara ahụike na ahụike nke onye ọrịa: A na-atụle ọkwa ahụike zuru oke nke onye ọrịa na akụkọ ahụike iji hụ na ọgwụgwọ ahụ dị mma ma dabara adaba. Ọnọdụ mgbochi ọrịa: Ịtụle usoro ahụ ji alụso ọrịa ọgụ nwere ike inye aka ịkọ nzaghachi ha na immunotherapy. Ime CIIC dịkwuo ọnụ ahịa: Akụkụ 'dị ọnụ ala' Ọ bụ ezie na ọ dị ọhụrụ, ọgwụgwọ ọrịa cancer ọhụrụ nwere ike ịdị ọnụ. A na-agba mbọ ime Chemoimmunotherapy Intratumoral ahaziri ahazi nke dị ọnụ ala-Opekempe ọzọ ịnwetanwu na ọnụ. Nke a gụnyere: Na-akpakọrịta ọnụ ahịa ọgwụ: Ụlọ ọgwụ na usoro ahụike nwere ike iso ndị ụlọ ọrụ na-emepụta ọgwụ kwurịta ka ha wedata ọnụ ahịa chemotherapy na ọgwụ immunotherapy. Iji ọgwụ ọ bụla: N'ebe ọ dị, ụdị ọgwụ chemotherapy dị iche iche nwere ike ibelata ụgwọ ọgwụgwọ. Usoro ọgwụgwọ kachasị mma: Ndị na-eme nchọpụta na-arụ ọrụ na-aga n'ihu iji kwalite usoro ọgwụgwọ iji mee ka ọ dị irè ma na-ebelata usoro ọgwụgwọ ọgwụ na ogologo oge ọgwụgwọ. Na-enyocha ihe ndị na-ahụ maka ọgwụ mgbochi ọrịa na-efu: Ụlọ ọrụ nyocha dị ka Shandong Baofa Cancer Research Institute na-arụsi ọrụ ike na-enyocha ihe ọhụrụ na ndị na-eri ọgwụ immunotherapeutic. Usoro mmezi: Imeziwanye arụmọrụ nke usoro ahụ, dị ka ịbelata oge ntinye aka na ibelata mkpa ụlọ ọgwụ, nwekwara ike belata ụgwọ ọrụ.Chemoimmunotherapy Agents Used Nhọrọ nke chemotherapy na immunotherapy na-adabere n'ụdị tumor, ogbo, na njirimara onye ọrịa. Ndị nnọchite anya gụnyere: Chemotherapy: Cisplatin, Carboplatin, Gemcitabine, Paclitaxel, Doxorubicin Immunotherapy: Ndị na-egbochi ihe mgbochi mgbochi (dịka, Pembrolizumab, Nivolumab), Interleukin-2 (IL-2), nje Oncolytic Usoro: Nzọụkwụ-site-nzọụkwụ Nlele onye ọrịa: A na-eme nyocha nke ọma iji chọpụta ntozu onye ọrịa. Onyonyo: A na-eme ọmụmụ ihe onyonyo (dịka, CT scan, ultrasound) iji hụ anya etu etuto ahụ na ntinye ntụ ntụ. Ntinye agịga: N'iji ntuziaka onyonyo, a na-etinye obere agịga site na akpụkpọ ahụ na n'ime etuto ahụ. Ịgbanye ọgwụ: A na-agbanye ọgwụ chemotherapy na/ma ọ bụ immunotherapy ozugbo n'ime etuto ahụ. Nleba anya: A na-enyocha onye ọrịa maka mmetụta ọjọọ ọ bụla. Nsoso: A na-ahazi nhọpụta nleba anya mgbe niile iji chọpụta nzaghachi ọgwụgwọ. Ihe ize ndụ nwere ike ime na mmetụta dị n'akụkụ ebe a na-anabatakarị nke ọma, chemoimmunotherapy intratumoral nwere ike ịnwe ihe ize ndụ na mmetụta ndị dị na ya, gụnyere: Ọrịa: Enwere ihe ize ndụ nke ibute ọrịa na saịtị ịgba ọgwụ. Ọbara: Ọbara nwere ike ime na ebe ịgba ọgwụ. Mgbu: Enwere ike ịnwe mgbu ma ọ bụ ahụ erughị ala na saịtị ịgba ọgwụ. Mmeghachi omume nfụkasị ahụ: Mmeghachi omume nfụkasị na chemotherapy ma ọ bụ ọgwụ immunotherapy nwere ike ime. Ọkụ Tumor: Mmụba nwa oge na nha etuto ma ọ bụ mbufụt nwere ike ime mgbe ọgwụgwọ gasịrị. Nsonaazụ na nyocha nyocha nke nyocha na nyocha nyocha egosila uru ndị nwere ike. Chemoimmunotherapy Intratumoral ahaziri ahazi nke dị ọnụ ala-Opekempe maka ụdị ọrịa cancer dị iche iche. A na-elekwasị anya na nyocha na-aga n'ihu: Usoro ọgwụgwọ kachasị mma: Na-ekpebi nchikota kacha mma na usoro onunu ogwu nke chemotherapy na immunotherapy. Ịmata Biomarkers amụma: Ịmata biomarkers nke nwere ike ibu amụma nzaghachi ọgwụgwọ. Ngwa na-agbasa: Na-enyocha iji intratumoral chemoimmunotherapy maka ụdị ọrịa kansa ndị ọzọ. CIIC ọ dabara gị? Chemoimmunotherapy Intratumoral ahaziri ahazi nke dị ọnụ ala-Opekempe bụ nhọrọ ọgwụgwọ ziri ezi chọrọ nyocha nke ọma site n'aka ọkachamara n'ihe gbasara oncologist. Gị na ndị otu ahụike gị kparịta ikpe gị n'otu n'otu na nhọrọ ọgwụgwọ gị iji mee mkpebi doro anya.Tụnyere Chemotherapy Omenala vs. Intratumoral Chemoimmunotherapy Feature Traditional Chemotherapy Intratumoral Chemoimmunotherapy Drug Delivery System (IV) Direct to Tumor System Toxicity High Lower Immune Stimulation Limited Invastical Intratumoral Chemoimmunotherapy. Enwere ike dị ala site na atụmatụ CIIC 'dị ọnụ ala' Mara: Tebụl ezubere maka naanị ihe atụ. Kpọtụrụ ọkachamara ahụike maka ndụmọdụ ahaziri onwe ya.MmechiChemoimmunotherapy Intratumoral ahaziri ahazi nke dị ọnụ ala-Opekempe na-enye ụzọ dị mma maka ọgwụgwọ ọrịa kansa site na ijikọta nkenke, ahaziri onwe ya na ọnụ ahịa nwere ike belata. Ka nyocha na-aga n'ihu na nnweta na-abawanye, ụzọ a nwere ike ịghọ ngwá ọrụ bara uru n'ọgụ megide ọrịa cancer. Ụlọ ọrụ dị ka Shandong Baofa Cancer Research Institute na-arụ ọrụ dị mkpa n'ịkwalite mpaghara a. Disclaimer: Edemede a bụ maka ebumnuche ozi naanị ọ bụghịkwa ndụmọdụ ahụike. Gakwuru onye ọkachamara ahụike tozuru etozu maka nsogbu ahụike ọ bụla ma ọ bụ tupu ịme mkpebi ọ bụla metụtara atụmatụ ọgwụgwọ gị.Emelitere ikpeazụ: [Ụbọchị]Usoro data na-adaberekarị na ihe ọmụma n'ozuzu ya na nyocha ebipụta na ngalaba nke oncology na immunology. Kpọtụrụ akwụkwọ akụkọ ahụike ama ama na ụlọ ọrụ nyocha ọrịa kansa maka ozi kacha zie ezie na nke ọhụrụ.